Fundraising Fox
Plasmagen Biosciences
Bengaluru, IN · Founded 2010 · 436 employees on LinkedIn · 1 known investors
Find your way into Plasmagen Biosciences
Sign up to see every warm intro you have to Plasmagen Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Plasmagen Biosciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.
Investors · 1
F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Related companies · 8
Biogen IdecBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
PepGenPepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
AmgenAmgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.
UrogenUroGen is a biotech company developing treatments for urothelial and specialty cancers using a proprietary sustained-release hydrogel platform technology. The company commercializes approved therapies for bladder and upper tract cancers, with additional candidates in development.
WugenAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
NervGen PharmaNervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.
Macrogenics IncMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
GlobaldataGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies working in the same space as Plasmagen Biosciences.
Frequently asked questions
- What does Plasmagen Biosciences do?
- PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.
- Who are Plasmagen Biosciences's investors?
- Plasmagen Biosciences's investors include F-Prime Capital.
- Where is Plasmagen Biosciences headquartered?
- Plasmagen Biosciences is headquartered in Bengaluru, IN.